Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Oesophageal bezoar as a complication of enteral nutrition in critically ill patients. Two case studies.
Intensive Crit Care Nurs
February 2016
Critical Care Unit C, Hospital Universitario Fundación Alcorcón, Budapest 1, 28922 Alcorcón, Madrid, Spain. Electronic address:
Enteral nutrition has a relatively low incidence of major complications. The most common complications are mechanical problems, bronchoaspiration and diarrhoea. A rare complication associated with the use of enteral nutrition is oesophageal bezoar.
View Article and Find Full Text PDFSucralfate-formed esophageal bezoar detected following sudden vomiting.
Endoscopy
March 2007
Department of Surgery, Tokai University School of Medicine, Bohseidai Isehara, Japan.
[Pharmacobezoar in a patient operated on for pyloric stenosis].
Farm Hosp
June 2004
Servicio de Farmacia, Complejo Hospitalario de Jaén.
Bezoars are concretions made up of a variety of partially digested materials seen in several portions of the gastrointestinal tract; they may result in gastrointestinal obstruction. Bezoar types described in the scientific literature include bezoars resulting from drugs. Their development is usually associated with some predisposing risk factor.
View Article and Find Full Text PDF[Sucralfate and bezoars: data from the system of pharmacologic vigilance and review of the literature].
Therapie
May 1999
Centre Régional de Pharmacovigilance et de Renseignements sur le Médicament, Hôpital de Bellevue, Saint-Etienne, France.
A bezoar is a mass of undigested material which may form within the lumen of the gut. Some drugs have the potential to form bezoars. In the majority of patients, there is a clear predisposing factor.
View Article and Find Full Text PDF[Esophageal bezoar in a child treated with sucralfate].
Arch Pediatr
July 1997
Service de réanimation pédiatrique, hôpital Charles-Nicolle, Rouen, France.
Background: Sucralfate is widely used in stress bleeding prophylaxis in intensive care units as it causes relatively few side effects. Its use in patients with risk factors may lead to the formation of esophageal bezoar. We describe the first known pediatric case of sucralfate esophageal bezoar.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!